Chris Cashman
Operating executive of early and mid-stage biopharmaceutical companies and major divisions of big pharma spanning the last 4 decades. Presently Chairman of MBF Therapeutics, Director of Noble Biomaterials, Polycore Therapeutics, Glutalor Inc. and University City Science Center. Advisor EpiVario Inc. and Telesis Therapeutics. Member of Mentor Connect Philadelphia. Former Chairman and CEO of Marinus Pharmaceuticals, Chairman JDP Therapeutics. CEO of Protez Pharmaceuticals, Message Pharmaceuticals. VP Pfizer, VP SmithKline Beecham.